$DNLI Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Denali Therapeutics Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in Denali Therapeutics Inc.. Get notifications about new insider transactions in Denali Therapeutics Inc. for free.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Aug 20 2020 | DNLI | Denali Therapeutic ... | Krognes Steve E. | CFO and Treasurer | Option Exercise | A | 0.00 | 20,000 | 0 | 20,000 | |
Aug 20 2020 | DNLI | Denali Therapeutic ... | Watts Ryan J. | President and CEO | Option Exercise | A | 0.00 | 20,000 | 0 | 20,000 | |
Aug 14 2020 | DNLI | Denali Therapeutic ... | BRATTON DOUGLAS K | 10% Owner | Sell | S | 31.65 | 1,443,247 | 45,678,768 | 12,201,634 | 13.6 M to 12.2 M (-10.58 %) |
Aug 14 2020 | DNLI | Denali Therapeutic ... | BRATTON DOUGLAS K | 10% Owner | Sell | S | 31.65 | 1,443,247 | 45,678,768 | 12,201,634 | 13.6 M to 12.2 M (-10.58 %) |
Jun 30 2020 | DNLI | Denali Therapeutic ... | BRATTON DOUGLAS K | 10% Owner | Sell | S | 24.34 | 200 | 4,868 | 448,035 | 448.2 K to 448 K (-0.04 %) |
Jun 30 2020 | DNLI | Denali Therapeutic ... | BRATTON DOUGLAS K | 10% Owner | Sell | S | 24.01 | 45,145 | 1,083,733 | 448,235 | 493.4 K to 448.2 K (-9.15 %) |
Jun 30 2020 | DNLI | Denali Therapeutic ... | BRATTON DOUGLAS K | 10% Owner | Sell | S | 24.50 | 20,771 | 508,975 | 493,380 | 514.2 K to 493.4 K (-4.04 %) |
Jun 30 2020 | DNLI | Denali Therapeutic ... | BRATTON DOUGLAS K | 10% Owner | Sell | S | 23.84 | 61,807 | 1,473,399 | 514,151 | 576 K to 514.2 K (-10.73 %) |
Jun 30 2020 | DNLI | Denali Therapeutic ... | BRATTON DOUGLAS K | 10% Owner | Sell | S | 24.67 | 13,604 | 335,637 | 575,958 | 589.6 K to 576 K (-2.31 %) |
Jun 30 2020 | DNLI | Denali Therapeutic ... | BRATTON DOUGLAS K | 10% Owner | Sell | S | 23.84 | 108,473 | 2,586,441 | 589,562 | 698 K to 589.6 K (-15.54 %) |
Jun 23 2020 | DNLI | Denali Therapeutic ... | BRATTON DOUGLAS K | 10% Owner | Sell | S | 26.19 | 3,247 | 85,028 | 698,035 | 701.3 K to 698 K (-0.46 %) |
Jun 23 2020 | DNLI | Denali Therapeutic ... | BRATTON DOUGLAS K | 10% Owner | Sell | S | 25.69 | 16,777 | 430,941 | 701,282 | 718.1 K to 701.3 K (-2.34 %) |
Jun 23 2020 | DNLI | Denali Therapeutic ... | BRATTON DOUGLAS K | 10% Owner | Sell | S | 25.12 | 24,683 | 619,960 | 718,059 | 742.7 K to 718.1 K (-3.32 %) |
Jun 23 2020 | DNLI | Denali Therapeutic ... | BRATTON DOUGLAS K | 10% Owner | Sell | S | 24.66 | 65,373 | 1,611,941 | 742,742 | 808.1 K to 742.7 K (-8.09 %) |
Jun 23 2020 | DNLI | Denali Therapeutic ... | BRATTON DOUGLAS K | 10% Owner | Sell | S | 25.00 | 62,439 | 1,560,850 | 808,115 | 870.6 K to 808.1 K (-7.17 %) |
Jun 23 2020 | DNLI | Denali Therapeutic ... | BRATTON DOUGLAS K | 10% Owner | Sell | S | 24.20 | 82,481 | 1,995,653 | 870,554 | 953 K to 870.6 K (-8.65 %) |
Jun 18 2020 | DNLI | Denali Therapeutic ... | Watts Ryan J. | President and CEO | Gift | G | 0.00 | 40,000 | 0 | 2,389,304 | 2.4 M to 2.4 M (-1.65 %) |
Jun 18 2020 | DNLI | Denali Therapeutic ... | Watts Ryan J. | President and CEO | Gift | G | 0.00 | 40,000 | 0 | 2,389,304 | 2.4 M to 2.4 M (-1.65 %) |
Jun 18 2020 | DNLI | Denali Therapeutic ... | Tessier-Lavigne Marc | Director | Sell | S | 26.10 | 400,000 | 10,440,000 | 2,739,043 | 3.1 M to 2.7 M (-12.74 %) |
Jun 18 2020 | DNLI | Denali Therapeutic ... | Tessier-Lavigne Marc | Director | Sell | S | 26.10 | 400,000 | 10,440,000 | 2,739,043 | 3.1 M to 2.7 M (-12.74 %) |
Jun 09 2020 | DNLI | Denali Therapeutic ... | BRATTON DOUGLAS K | 10% Owner | Sell | S | 25.75 | 1,922,855 | 49,513,516 | 13,644,881 | 15.6 M to 13.6 M (-12.35 %) |
Jun 05 2020 | DNLI | Denali Therapeutic ... | SATO VICKI L | Director | Option Exercise | A | 0.00 | 3,253 | 0 | 3,253 | |
Jun 05 2020 | DNLI | Denali Therapeutic ... | SATO VICKI L | Director | Option Exercise | A | 28.82 | 15,183 | 437,574 | 15,183 | |
Jun 05 2020 | DNLI | Denali Therapeutic ... | Schenkein David P | Director | Option Exercise | A | 0.00 | 3,253 | 0 | 3,253 | |
Jun 05 2020 | DNLI | Denali Therapeutic ... | Schenkein David P | Director | Option Exercise | A | 28.82 | 15,183 | 437,574 | 15,183 | |
Jun 05 2020 | DNLI | Denali Therapeutic ... | NELSEN ROBERT | Director | Option Exercise | A | 0.00 | 3,253 | 0 | 3,253 | |
Jun 05 2020 | DNLI | Denali Therapeutic ... | NELSEN ROBERT | Director | Option Exercise | A | 28.82 | 15,183 | 437,574 | 15,183 | |
Jun 05 2020 | DNLI | Denali Therapeutic ... | Klein Peter S | Director | Option Exercise | A | 0.00 | 3,253 | 0 | 3,253 | |
Jun 05 2020 | DNLI | Denali Therapeutic ... | Klein Peter S | Director | Option Exercise | A | 28.82 | 15,183 | 437,574 | 15,183 | |
Jun 05 2020 | DNLI | Denali Therapeutic ... | Tessier-Lavigne Marc | Director | Option Exercise | A | 0.00 | 3,253 | 0 | 3,253 | |
Jun 05 2020 | DNLI | Denali Therapeutic ... | Tessier-Lavigne Marc | Director | Option Exercise | A | 28.82 | 15,183 | 437,574 | 15,183 | |
Jun 05 2020 | DNLI | Denali Therapeutic ... | FLATLEY JAY T | Director | Option Exercise | A | 0.00 | 3,253 | 0 | 3,253 | |
Jun 05 2020 | DNLI | Denali Therapeutic ... | FLATLEY JAY T | Director | Option Exercise | A | 28.82 | 15,183 | 437,574 | 15,183 | |
Jun 05 2020 | DNLI | Denali Therapeutic ... | Cook Jennifer E. | Director | Option Exercise | A | 0.00 | 3,253 | 0 | 3,253 | |
Jun 05 2020 | DNLI | Denali Therapeutic ... | Cook Jennifer E. | Director | Option Exercise | A | 28.82 | 15,183 | 437,574 | 15,183 | |
Jun 05 2020 | DNLI | Denali Therapeutic ... | Cole Douglas G. | Director | Option Exercise | A | 0.00 | 3,253 | 0 | 3,253 | |
Jun 05 2020 | DNLI | Denali Therapeutic ... | Cole Douglas G. | Director | Option Exercise | A | 28.82 | 15,183 | 437,574 | 15,183 | |
Apr 01 2020 | DNLI | Denali Therapeutic ... | Krognes Steve E. | CFO and Treasurer | Sell | S | 19.48 | 1,428 | 27,817 | 1,006,488 | 1 M to 1 M (-0.14 %) |
Apr 01 2020 | DNLI | Denali Therapeutic ... | Schuth Alexander O. | COO and Secretary | Sell | S | 19.49 | 1,427 | 27,812 | 28,662 | 30.1 K to 28.7 K (-4.74 %) |
Apr 01 2020 | DNLI | Denali Therapeutic ... | Ho Carole | Chief Medical Offic ... | Sell | S | 19.48 | 1,428 | 27,817 | 2,822 | 4.3 K to 2.8 K (-33.60 %) |
Apr 01 2020 | DNLI | Denali Therapeutic ... | Watts Ryan J. | President and CEO | Sell | S | 19.48 | 4,807 | 93,640 | 22,013 | 26.8 K to 22 K (-17.92 %) |
Feb 12 2020 | DNLI | Denali Therapeutic ... | Schuth Alexander O. | COO and Secretary | Option Exercise | A | 24.81 | 136,000 | 3,374,160 | 136,000 | |
Feb 12 2020 | DNLI | Denali Therapeutic ... | Schuth Alexander O. | COO and Secretary | Option Exercise | A | 0.00 | 29,143 | 0 | 29,143 | |
Feb 12 2020 | DNLI | Denali Therapeutic ... | Krognes Steve E. | CFO and Treasurer | Option Exercise | A | 24.81 | 136,000 | 3,374,160 | 136,000 | |
Feb 12 2020 | DNLI | Denali Therapeutic ... | Krognes Steve E. | CFO and Treasurer | Option Exercise | A | 0.00 | 29,143 | 0 | 29,143 | |
Feb 12 2020 | DNLI | Denali Therapeutic ... | Watts Ryan J. | President and CEO | Option Exercise | A | 24.81 | 367,675 | 9,122,017 | 367,675 | |
Feb 12 2020 | DNLI | Denali Therapeutic ... | Watts Ryan J. | President and CEO | Option Exercise | A | 0.00 | 78,787 | 0 | 78,787 | |
Feb 12 2020 | DNLI | Denali Therapeutic ... | Ho Carole | Chief Medical Offic ... | Option Exercise | A | 24.81 | 142,000 | 3,523,020 | 142,000 | |
Feb 12 2020 | DNLI | Denali Therapeutic ... | Ho Carole | Chief Medical Offic ... | Option Exercise | A | 0.00 | 29,874 | 0 | 29,874 | |
Dec 23 2019 | DNLI | Denali Therapeutic ... | Ho Carole | Chief Medical Offic ... | Sell | S | 20.01 | 3,464 | 69,315 | 0 | 3.5 K to 0 (-100.00 %) |
Dec 23 2019 | DNLI | Denali Therapeutic ... | Ho Carole | Chief Medical Offic ... | Sell | S | 20.00 | 860 | 17,200 | 3,464 | 4.3 K to 3.5 K (-19.89 %) |
Dec 23 2019 | DNLI | Denali Therapeutic ... | Ho Carole | Chief Medical Offic ... | Sell | S | 20.00 | 2,566 | 51,320 | 4,324 | 6.9 K to 4.3 K (-37.24 %) |
Dec 05 2019 | DNLI | Denali Therapeutic ... | Schuth Alexander O. | COO and Secretary | Option Exercise | M | 5.28 | 3,121 | 16,479 | 108,937 | |
Dec 05 2019 | DNLI | Denali Therapeutic ... | Schuth Alexander O. | COO and Secretary | Option Exercise | M | 5.28 | 711 | 3,754 | 112,058 | |
Dec 05 2019 | DNLI | Denali Therapeutic ... | Schuth Alexander O. | COO and Secretary | Sell | S | 18.00 | 3,121 | 56,178 | 25,839 | 29 K to 25.8 K (-10.78 %) |
Dec 05 2019 | DNLI | Denali Therapeutic ... | Schuth Alexander O. | COO and Secretary | Buy | M | 5.28 | 3,121 | 16,479 | 28,960 | 25.8 K to 29 K (+12.08 %) |
Dec 05 2019 | DNLI | Denali Therapeutic ... | Schuth Alexander O. | COO and Secretary | Sell | S | 18.00 | 2,656 | 47,808 | 580,710 | 583.4 K to 580.7 K (-0.46 %) |
Dec 05 2019 | DNLI | Denali Therapeutic ... | Schuth Alexander O. | COO and Secretary | Sell | S | 18.01 | 711 | 12,805 | 25,839 | 26.6 K to 25.8 K (-2.68 %) |
Dec 05 2019 | DNLI | Denali Therapeutic ... | Schuth Alexander O. | COO and Secretary | Buy | M | 5.28 | 711 | 3,754 | 26,550 | 25.8 K to 26.6 K (+2.75 %) |
Dec 05 2019 | DNLI | Denali Therapeutic ... | Schuth Alexander O. | COO and Secretary | Sell | S | 18.01 | 1,012 | 18,226 | 583,366 | 584.4 K to 583.4 K (-0.17 %) |
Dec 05 2019 | DNLI | Denali Therapeutic ... | Watts Ryan J. | President and CEO | Sell | S | 18.00 | 18,755 | 337,590 | 2,429,304 | 2.4 M to 2.4 M (-0.77 %) |
Dec 05 2019 | DNLI | Denali Therapeutic ... | Watts Ryan J. | President and CEO | Sell | S | 18.02 | 2,513 | 45,284 | 2,448,059 | 2.5 M to 2.4 M (-0.10 %) |
Nov 26 2019 | DNLI | Denali Therapeutic ... | Watts Ryan J. | President and CEO | Sell | S | 18.02 | 42,185 | 760,174 | 2,450,572 | 2.5 M to 2.5 M (-1.69 %) |
Nov 26 2019 | DNLI | Denali Therapeutic ... | Watts Ryan J. | President and CEO | Sell | S | 18.00 | 1,300 | 23,400 | 2,492,757 | 2.5 M to 2.5 M (-0.05 %) |
Nov 26 2019 | DNLI | Denali Therapeutic ... | Schuth Alexander O. | COO and Secretary | Sell | S | 18.02 | 229 | 4,127 | 584,378 | 584.6 K to 584.4 K (-0.04 %) |
Nov 26 2019 | DNLI | Denali Therapeutic ... | Schuth Alexander O. | COO and Secretary | Sell | S | 18.02 | 14,125 | 254,533 | 584,607 | 598.7 K to 584.6 K (-2.36 %) |
Nov 26 2019 | DNLI | Denali Therapeutic ... | Schuth Alexander O. | COO and Secretary | Sell | S | 18.00 | 646 | 11,628 | 598,732 | 599.4 K to 598.7 K (-0.11 %) |
Oct 25 2019 | DNLI | Denali Therapeutic ... | Schuth Alexander O. | COO and Secretary | Option Exercise | M | 5.28 | 5,129 | 27,081 | 112,769 | |
Oct 25 2019 | DNLI | Denali Therapeutic ... | Schuth Alexander O. | COO and Secretary | Buy | M | 5.28 | 5,129 | 27,081 | 25,839 | 20.7 K to 25.8 K (+24.77 %) |
Sep 11 2019 | DNLI | Denali Therapeutic ... | Schuth Alexander O. | COO and Secretary | Sell | S | 18.16 | 7,500 | 136,200 | 610,089 | 617.6 K to 610.1 K (-1.21 %) |
Sep 05 2019 | DNLI | Denali Therapeutic ... | Watts Ryan J. | President and CEO | Sell | S | 18.09 | 4,847 | 87,682 | 2,494,057 | 2.5 M to 2.5 M (-0.19 %) |
Sep 05 2019 | DNLI | Denali Therapeutic ... | Watts Ryan J. | President and CEO | Sell | S | 18.00 | 3,734 | 67,212 | 2,498,904 | 2.5 M to 2.5 M (-0.15 %) |
Aug 22 2019 | DNLI | Denali Therapeutic ... | Schuth Alexander O. | COO and Secretary | Option Exercise | M | 0.00 | 5,643 | 0 | 5,643 | |
Aug 22 2019 | DNLI | Denali Therapeutic ... | Schuth Alexander O. | COO and Secretary | Payment of Exercise | F | 18.60 | 1,975 | 36,731 | 20,710 | 22.7 K to 20.7 K (-8.71 %) |
Aug 22 2019 | DNLI | Denali Therapeutic ... | Schuth Alexander O. | COO and Secretary | Buy | M | 0.00 | 5,643 | 0 | 22,685 | 17 K to 22.7 K (+33.11 %) |
Aug 22 2019 | DNLI | Denali Therapeutic ... | Ho Carole | Chief Medical Offic ... | Option Exercise | M | 0.00 | 5,643 | 0 | 5,643 | |
Aug 22 2019 | DNLI | Denali Therapeutic ... | Ho Carole | Chief Medical Offic ... | Payment of Exercise | F | 18.59 | 2,834 | 52,671 | 49,684 | 52.5 K to 49.7 K (-5.40 %) |
Aug 22 2019 | DNLI | Denali Therapeutic ... | Ho Carole | Chief Medical Offic ... | Buy | M | 0.00 | 5,643 | 0 | 52,518 | 46.9 K to 52.5 K (+12.04 %) |
Aug 22 2019 | DNLI | Denali Therapeutic ... | Krognes Steve E. | CFO and Treasurer | Option Exercise | M | 0.00 | 5,643 | 0 | 5,643 | |
Aug 22 2019 | DNLI | Denali Therapeutic ... | Krognes Steve E. | CFO and Treasurer | Payment of Exercise | F | 18.59 | 1,977 | 36,745 | 1,003,666 | 1 M to 1 M (-0.20 %) |
Aug 22 2019 | DNLI | Denali Therapeutic ... | Krognes Steve E. | CFO and Treasurer | Buy | M | 0.00 | 5,643 | 0 | 1,005,643 | 1000 K to 1 M (+0.56 %) |
Aug 12 2019 | DNLI | Denali Therapeutic ... | NELSEN ROBERT | Director | Buy | J | 0.00 | 2,030 | 0 | 2,030 | 0 to 2 K |
Aug 12 2019 | DNLI | Denali Therapeutic ... | NELSEN ROBERT | Director | Sell | J | 0.00 | 400,000 | 0 | 10,668,749 | 11.1 M to 10.7 M (-3.61 %) |
Aug 12 2019 | DNLI | Denali Therapeutic ... | ARCH Venture Fund VIII, L.P. | 10% Owner | Sell | J | 0.00 | 400,000 | 0 | 10,668,749 | 11.1 M to 10.7 M (-3.61 %) |
Aug 09 2019 | DNLI | Denali Therapeutic ... | Schuth Alexander O. | COO and Secretary | Sell | S | 18.81 | 7,500 | 141,075 | 617,589 | 625.1 K to 617.6 K (-1.20 %) |
Jul 10 2019 | DNLI | Denali Therapeutic ... | Schuth Alexander O. | COO and Secretary | Sell | S | 20.90 | 400 | 8,360 | 625,089 | 625.5 K to 625.1 K (-0.06 %) |
Jul 10 2019 | DNLI | Denali Therapeutic ... | Schuth Alexander O. | COO and Secretary | Sell | S | 20.25 | 7,100 | 143,775 | 625,489 | 632.6 K to 625.5 K (-1.12 %) |
Jul 10 2019 | DNLI | Denali Therapeutic ... | Ho Carole | Chief Medical Offic ... | Option Exercise | M | 5.28 | 3,907 | 20,629 | 78,126 | |
Jul 10 2019 | DNLI | Denali Therapeutic ... | Ho Carole | Chief Medical Offic ... | Option Exercise | M | 5.28 | 2,604 | 13,749 | 92,565 | |
Jul 10 2019 | DNLI | Denali Therapeutic ... | Ho Carole | Chief Medical Offic ... | Sell | S | 20.88 | 1,100 | 22,968 | 79,934 | 81 K to 79.9 K (-1.36 %) |
Jul 10 2019 | DNLI | Denali Therapeutic ... | Ho Carole | Chief Medical Offic ... | Sell | S | 20.21 | 9,889 | 199,857 | 81,034 | 90.9 K to 81 K (-10.88 %) |
Jul 10 2019 | DNLI | Denali Therapeutic ... | Ho Carole | Chief Medical Offic ... | Sell | S | 20.55 | 3,907 | 80,289 | 4,081 | 8 K to 4.1 K (-48.91 %) |
Jul 10 2019 | DNLI | Denali Therapeutic ... | Ho Carole | Chief Medical Offic ... | Buy | M | 5.28 | 3,907 | 20,629 | 7,988 | 4.1 K to 8 K (+95.74 %) |
Jul 10 2019 | DNLI | Denali Therapeutic ... | Ho Carole | Chief Medical Offic ... | Sell | S | 19.93 | 2,604 | 51,898 | 4,081 | 6.7 K to 4.1 K (-38.95 %) |
Jul 10 2019 | DNLI | Denali Therapeutic ... | Ho Carole | Chief Medical Offic ... | Buy | M | 5.28 | 2,604 | 13,749 | 6,685 | 4.1 K to 6.7 K (+63.81 %) |
Jul 03 2019 | DNLI | Denali Therapeutic ... | Watts Ryan J. | President and CEO | Sell | S | 20.76 | 18,333 | 380,593 | 2,502,638 | 2.5 M to 2.5 M (-0.73 %) |
Jul 03 2019 | DNLI | Denali Therapeutic ... | Watts Ryan J. | President and CEO | Gift | G | 0.00 | 40,000 | 0 | 2,520,971 | 2.6 M to 2.5 M (-1.56 %) |
Jun 12 2019 | DNLI | Denali Therapeutic ... | Schuth Alexander O. | COO and Secretary | Sell | S | 18.77 | 7,500 | 140,775 | 632,589 | 640.1 K to 632.6 K (-1.17 %) |
Jun 12 2019 | DNLI | Denali Therapeutic ... | Ho Carole | Chief Medical Offic ... | Option Exercise | M | 5.28 | 3,906 | 20,624 | 82,033 | |
Jun 12 2019 | DNLI | Denali Therapeutic ... | Ho Carole | Chief Medical Offic ... | Option Exercise | M | 5.28 | 711 | 3,754 | 95,169 | |
Jun 12 2019 | DNLI | Denali Therapeutic ... | Ho Carole | Chief Medical Offic ... | Sell | S | 18.78 | 12,883 | 241,943 | 90,923 | 103.8 K to 90.9 K (-12.41 %) |
Jun 12 2019 | DNLI | Denali Therapeutic ... | Ho Carole | Chief Medical Offic ... | Sell | S | 18.81 | 3,906 | 73,472 | 0 | 3.9 K to 0 (-100.00 %) |
Jun 12 2019 | DNLI | Denali Therapeutic ... | Ho Carole | Chief Medical Offic ... | Buy | M | 5.28 | 3,906 | 20,624 | 3,906 | 0 to 3.9 K |
Jun 12 2019 | DNLI | Denali Therapeutic ... | Ho Carole | Chief Medical Offic ... | Sell | S | 18.62 | 711 | 13,239 | 0 | 711 to 0 (-100.00 %) |
Jun 12 2019 | DNLI | Denali Therapeutic ... | Ho Carole | Chief Medical Offic ... | Buy | M | 5.28 | 711 | 3,754 | 711 | 0 to 711 |
Jun 05 2019 | DNLI | Denali Therapeutic ... | Watts Ryan J. | President and CEO | Sell | S | 19.07 | 18,333 | 349,610 | 2,560,971 | 2.6 M to 2.6 M (-0.71 %) |
Jun 03 2019 | DNLI | Denali Therapeutic ... | Schenkein David P | Director | Option Exercise | A | 19.50 | 27,245 | 531,278 | 27,245 | |
Jun 03 2019 | DNLI | Denali Therapeutic ... | NELSEN ROBERT | Director | Option Exercise | A | 19.50 | 27,245 | 531,278 | 27,245 | |
May 31 2019 | DNLI | Denali Therapeutic ... | SATO VICKI L | Director | Option Exercise | A | 19.50 | 27,245 | 531,278 | 27,245 | |
May 31 2019 | DNLI | Denali Therapeutic ... | Klein Peter S | Director | Option Exercise | A | 19.50 | 27,245 | 531,278 | 27,245 | |
May 31 2019 | DNLI | Denali Therapeutic ... | Tessier-Lavigne Marc | Director | Option Exercise | A | 19.50 | 27,245 | 531,278 | 27,245 | |
May 31 2019 | DNLI | Denali Therapeutic ... | FLATLEY JAY T | Director | Option Exercise | A | 19.50 | 27,245 | 531,278 | 27,245 | |
May 31 2019 | DNLI | Denali Therapeutic ... | Cook Jennifer E. | Director | Option Exercise | A | 19.50 | 27,245 | 531,278 | 27,245 | |
May 31 2019 | DNLI | Denali Therapeutic ... | Cole Douglas G. | Director | Option Exercise | A | 19.50 | 27,245 | 531,278 | 27,245 | |
May 13 2019 | DNLI | Denali Therapeutic ... | Schuth Alexander O. | COO and Secretary | Sell | S | 21.09 | 2,500 | 52,725 | 640,089 | 642.6 K to 640.1 K (-0.39 %) |
May 13 2019 | DNLI | Denali Therapeutic ... | Schuth Alexander O. | COO and Secretary | Sell | S | 21.09 | 2,500 | 52,725 | 640,089 | 642.6 K to 640.1 K (-0.39 %) |
May 13 2019 | DNLI | Denali Therapeutic ... | Schuth Alexander O. | COO and Secretary | Sell | S | 22.19 | 2,500 | 55,475 | 642,589 | 645.1 K to 642.6 K (-0.39 %) |
May 13 2019 | DNLI | Denali Therapeutic ... | Schuth Alexander O. | COO and Secretary | Sell | S | 22.19 | 2,500 | 55,475 | 642,589 | 645.1 K to 642.6 K (-0.39 %) |
May 13 2019 | DNLI | Denali Therapeutic ... | Schuth Alexander O. | COO and Secretary | Sell | S | 22.86 | 2,500 | 57,150 | 645,089 | 647.6 K to 645.1 K (-0.39 %) |
May 13 2019 | DNLI | Denali Therapeutic ... | Schuth Alexander O. | COO and Secretary | Sell | S | 22.86 | 2,500 | 57,150 | 645,089 | 647.6 K to 645.1 K (-0.39 %) |
May 10 2019 | DNLI | Denali Therapeutic ... | Ho Carole | Chief Medical Offic ... | Option Exercise | M | 5.28 | 2,546 | 13,443 | 85,939 | |
May 10 2019 | DNLI | Denali Therapeutic ... | Ho Carole | Chief Medical Offic ... | Option Exercise | M | 5.28 | 2,653 | 14,008 | 88,485 | |
May 10 2019 | DNLI | Denali Therapeutic ... | Ho Carole | Chief Medical Offic ... | Option Exercise | M | 5.28 | 2,613 | 13,797 | 91,138 | |
May 10 2019 | DNLI | Denali Therapeutic ... | Ho Carole | Chief Medical Offic ... | Sell | S | 22.16 | 3,316 | 73,483 | 103,806 | 107.1 K to 103.8 K (-3.10 %) |
May 10 2019 | DNLI | Denali Therapeutic ... | Ho Carole | Chief Medical Offic ... | Sell | S | 22.17 | 2,546 | 56,445 | 0 | 2.5 K to 0 (-100.00 %) |
May 10 2019 | DNLI | Denali Therapeutic ... | Ho Carole | Chief Medical Offic ... | Buy | M | 5.28 | 2,546 | 13,443 | 2,546 | 0 to 2.5 K |
May 10 2019 | DNLI | Denali Therapeutic ... | Ho Carole | Chief Medical Offic ... | Sell | S | 23.60 | 200 | 4,720 | 107,122 | 107.3 K to 107.1 K (-0.19 %) |
May 10 2019 | DNLI | Denali Therapeutic ... | Ho Carole | Chief Medical Offic ... | Sell | S | 22.83 | 3,010 | 68,718 | 107,322 | 110.3 K to 107.3 K (-2.73 %) |
May 10 2019 | DNLI | Denali Therapeutic ... | Ho Carole | Chief Medical Offic ... | Sell | S | 23.58 | 200 | 4,716 | 0 | 200 to 0 (-100.00 %) |
May 10 2019 | DNLI | Denali Therapeutic ... | Ho Carole | Chief Medical Offic ... | Sell | S | 22.86 | 2,453 | 56,076 | 200 | 2.7 K to 200 (-92.46 %) |
May 10 2019 | DNLI | Denali Therapeutic ... | Ho Carole | Chief Medical Offic ... | Buy | M | 5.28 | 2,653 | 14,008 | 2,653 | 0 to 2.7 K |
May 10 2019 | DNLI | Denali Therapeutic ... | Ho Carole | Chief Medical Offic ... | Sell | S | 23.51 | 3,162 | 74,339 | 110,332 | 113.5 K to 110.3 K (-2.79 %) |
May 10 2019 | DNLI | Denali Therapeutic ... | Ho Carole | Chief Medical Offic ... | Sell | S | 23.50 | 2,613 | 61,406 | 0 | 2.6 K to 0 (-100.00 %) |
May 10 2019 | DNLI | Denali Therapeutic ... | Ho Carole | Chief Medical Offic ... | Buy | M | 5.28 | 2,613 | 13,797 | 2,613 | 0 to 2.6 K |
May 03 2019 | DNLI | Denali Therapeutic ... | Watts Ryan J. | President and CEO | Sell | S | 24.49 | 6,111 | 149,658 | 2,579,304 | 2.6 M to 2.6 M (-0.24 %) |
May 03 2019 | DNLI | Denali Therapeutic ... | Watts Ryan J. | President and CEO | Sell | S | 24.03 | 6,111 | 146,847 | 2,585,415 | 2.6 M to 2.6 M (-0.24 %) |
May 03 2019 | DNLI | Denali Therapeutic ... | Watts Ryan J. | President and CEO | Sell | S | 24.09 | 6,112 | 147,238 | 2,591,526 | 2.6 M to 2.6 M (-0.24 %) |
Apr 11 2019 | DNLI | Denali Therapeutic ... | Schuth Alexander O. | COO and Secretary | Sell | S | 27.73 | 2,512 | 69,658 | 647,589 | 650.1 K to 647.6 K (-0.39 %) |
Apr 11 2019 | DNLI | Denali Therapeutic ... | Schuth Alexander O. | COO and Secretary | Sell | S | 28.26 | 2,513 | 71,017 | 650,101 | 652.6 K to 650.1 K (-0.39 %) |
Apr 11 2019 | DNLI | Denali Therapeutic ... | Schuth Alexander O. | COO and Secretary | Sell | S | 28.17 | 2,475 | 69,721 | 652,614 | 655.1 K to 652.6 K (-0.38 %) |
Apr 09 2019 | DNLI | Denali Therapeutic ... | BRATTON DOUGLAS K | 10% Owner | Sell | J | 0.00 | 158,764 | 0 | 953,035 | 1.1 M to 953 K (-14.28 %) |
Apr 09 2019 | DNLI | Denali Therapeutic ... | BRATTON DOUGLAS K | 10% Owner | Sell | J | 0.00 | 158,764 | 0 | 953,035 | 1.1 M to 953 K (-14.28 %) |
Apr 08 2019 | DNLI | Denali Therapeutic ... | Ho Carole | Chief Medical Offic ... | Sell | S | 27.00 | 1,433 | 38,691 | 113,494 | 114.9 K to 113.5 K (-1.25 %) |
Apr 08 2019 | DNLI | Denali Therapeutic ... | Ho Carole | Chief Medical Offic ... | Sell | S | 26.24 | 8,155 | 213,987 | 114,927 | 123.1 K to 114.9 K (-6.63 %) |
Apr 03 2019 | DNLI | Denali Therapeutic ... | Ho Carole | Chief Medical Offic ... | Option Exercise | M | 5.28 | 5,862 | 30,951 | 93,858 | |
Apr 03 2019 | DNLI | Denali Therapeutic ... | Ho Carole | Chief Medical Offic ... | Option Exercise | M | 5.28 | 6,135 | 32,393 | 99,720 | |
Apr 03 2019 | DNLI | Denali Therapeutic ... | Ho Carole | Chief Medical Offic ... | Option Exercise | M | 5.28 | 5,775 | 30,492 | 105,855 | |
Apr 03 2019 | DNLI | Denali Therapeutic ... | Ho Carole | Chief Medical Offic ... | Sell | S | 26.79 | 900 | 24,111 | 123,082 | 124 K to 123.1 K (-0.73 %) |
Apr 03 2019 | DNLI | Denali Therapeutic ... | Ho Carole | Chief Medical Offic ... | Sell | S | 26.29 | 8,688 | 228,408 | 123,982 | 132.7 K to 124 K (-6.55 %) |
Apr 03 2019 | DNLI | Denali Therapeutic ... | Ho Carole | Chief Medical Offic ... | Sell | S | 26.81 | 600 | 16,086 | 0 | 600 to 0 (-100.00 %) |